Source: Pharmacological Research. Unidade: ICB
Subjects: FARMACOLOGIA, ASMA, BETA-BLOQUEADORES, ANTAGONISMO DE DROGAS, LEUCOTRIENOS B, INFLAMAÇÃO, ADRENÉRGICOS, SAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
ABNT
CERQUA, Ida et al. Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy. Pharmacological Research, v. 186, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2022.106536. Acesso em: 17 ago. 2024.APA
Cerqua, I., Granato, E., Petti, A., Pavese, R., Costa, S. K. P., Feitosa, K. B., et al. (2022). Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy. Pharmacological Research, 186, 1-14. doi:10.1016/j.phrs.2022.106536NLM
Cerqua I, Granato E, Petti A, Pavese R, Costa SKP, Feitosa KB, Soares Junior AG, Camerlingo R. Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy [Internet]. Pharmacological Research. 2022 ; 186 1-14.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.phrs.2022.106536Vancouver
Cerqua I, Granato E, Petti A, Pavese R, Costa SKP, Feitosa KB, Soares Junior AG, Camerlingo R. Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy [Internet]. Pharmacological Research. 2022 ; 186 1-14.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1016/j.phrs.2022.106536